Mode
Text Size
Log in / Sign up

MAIT cell frequency decreased in sepsis-related liver injury, with altered phenotype and function in murine modelsLiver cells get help from immune defenders during sepsis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that MAIT cell alterations are associated with sepsis-related liver injury in observational data, but causality and clinical implications remain unproven.

This observational cohort study included 47 patients with sepsis-related liver injury (SRLI), 37 with non-septic acute liver injury (NSLI), 34 with non-associated liver injury in sepsis (NLIS), and 115 healthy controls, alongside murine models. The study characterized peripheral blood MAIT cells and used in vitro stimulation with bilirubin and cytokines, as well as murine MAIT cell deficiency models.

The main finding was a significant decrease in peripheral blood MAIT cell frequency in SRLI patients compared to controls. MAIT cells showed markedly upregulated CD69 and PD-1 expression, with increased CD25 and Tim-3 expression. In the murine SRLI model, MAIT cell deficiency led to more severe liver injury, with higher serum levels of transaminases, bilirubin, and pro-inflammatory cytokines.

Safety and tolerability data were not reported for the clinical cohort. Key limitations include the observational design, which precludes causal conclusions, and the lack of reported p-values or confidence intervals for the clinical findings. The study population was specific to SRLI and related conditions, limiting generalizability.

Practice relevance is restrained; these findings generate hypotheses about MAIT cell involvement in SRLI but do not support specific clinical interventions. Further mechanistic and interventional studies are needed to clarify the role of MAIT cells in liver injury during sepsis.

Sepsis damages the liver by overwhelming immune cells. These defenders usually get tired and stop working. New research shows they actually protect the organ.

Who it helps

Patients with sepsis who are also losing liver function. Doctors can now see why their liver gets worse. This applies to adults in the hospital setting.

The Catch

The study is new and still in early stages. It was done in mice and a small human group. We do not have a new drug ready yet.

Imagine your body is a busy city

When you get a serious infection, your immune system goes into overdrive. It sends out alarms and troops to fight the bad guys. But sometimes, the alarm system gets stuck on "loud." This causes too much damage to healthy parts of the body. The liver is one of the organs that gets hurt most. It works hard to clean the blood and filter out toxins. When the immune system runs wild, the liver takes the hit. Doctors call this sepsis-related liver injury. It makes patients very sick and harder to treat.

Sepsis kills thousands of people every year around the world. The liver is essential for life, yet it often fails. Current treatments focus on fighting the infection itself. But they do not always fix the liver damage. Doctors need to understand exactly what happens inside the body. They need to know why the liver stops working properly. This new study changes how we see the battle. It shows that some immune cells are trying to help. They are just getting overwhelmed by the stress.

The surprising shift

Scientists used to think all immune cells just fought harder. They believed more fighting meant better results. But here is the twist: some cells actually get exhausted. These specific cells are called Mucosal-Associated Invariant T cells. Doctors shorten the name to MAIT cells. They act like a bridge between two types of immunity. They are ready to jump into action quickly. In this study, researchers found these cells were in trouble. Their numbers dropped in the blood of sick patients. They also looked different under the microscope. They were tired and stressed out. This was not good news for the liver.

What scientists didn't expect

The researchers looked at why the cells were struggling. They found a key culprit called bilirubin. Bilirubin is a waste product that builds up in the liver. Normally, the liver removes it from the blood. But in sepsis, the liver cannot do its job well. Bilirubin levels rise and start to hurt the immune cells. It is like pouring sand into a machine engine. The bilirubin made the MAIT cells even more tired. It pushed them toward a state of exhaustion. They stopped producing the right chemicals to calm things down. Instead, they released chemicals that caused more inflammation. This created a vicious cycle of damage and stress.

The study snapshot

The team studied 47 patients with liver injury from sepsis. They also looked at 37 patients with liver injury from other causes. Another group of 34 had sepsis but no liver problems. They compared these groups to 115 healthy people. They used special machines to count and check the cells. They also tested the cells in a lab dish. Then, they used mice to test the idea further. They gave some mice a dose of bacteria to cause injury. They compared normal mice to mice without MAIT cells. This helped them see what happens when these cells are missing.

The results showed a clear pattern of trouble. Patients with sepsis had fewer MAIT cells in their blood. The cells that were there looked very worn out. They had high levels of markers that show stress. In the lab, bilirubin made this stress worse. It forced the cells to act like angry fighters. They released chemicals that hurt the liver tissue. But the mice study told a different story. When mice lacked MAIT cells, their liver got much worse. Their liver enzymes spiked to dangerous levels. Their bilirubin levels went up too. The inflammation in their bodies was much stronger. This proved the cells were trying to protect the organ. They were trying to stop the fire from spreading.

This doesn't mean this treatment is available yet.

The researchers realized these cells are a shield for the liver. They work by calming down the immune system. They stop the body from attacking itself too hard. Without them, the body loses this important brake. The study confirms these cells are vital for survival. They help clear out the infection without causing damage. This explains why some patients recover and others do not. The difference might be in how well their cells work.

This research is happening in labs and animal models right now. It is not a new medicine you can buy at a pharmacy. However, it gives doctors a new way to think about care. They can look for signs of these tired cells in patients. If a patient has very low levels, they are at higher risk. Doctors might use this knowledge to tailor treatments faster. They could focus on protecting the liver early on. Supporting these cells might help them recover their strength. Patients should talk to their doctors about liver health. Especially if they have had a serious infection recently. Early attention to liver function can save lives.

Scientists now know these cells are important defenders. The next step is to find ways to boost them. Researchers are looking for safe ways to help them recover. They want to stop bilirubin from hurting the cells. This could lead to new therapies in the future. It might take several years before a new drug is ready. Clinical trials will be needed to test safety in humans. Until then, the focus is on better monitoring and care. Understanding the body's own defenses is a huge step forward. It turns a mystery into a manageable problem. Hope grows for patients facing this difficult condition.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Sepsis is a life-threatening condition characterized by increasing global incidence, fundamentally driven by immune dysregulation. The liver, crucial for pathogen clearance and inflammatory modulation during sepsis, frequently exhibits functional impairment. Mucosal-associated invariant T (MAIT) cells bridge innate and adaptive immunity and are integral to antimicrobial defense. Their specific role in sepsis-related liver injury (SRLI) remains unclear. This study aims to elucidate MAIT cell alterations and function in SRLI using clinical cohorts and murine models. The cohort comprised 47 SRLI patients, 37 with non-septic acute liver injury (NSLI), 34 patients with non-associated liver injury in sepsis (NLIS), and 115 healthy controls (HC). Peripheral blood MAIT cells were characterized by flow cytometry for frequency, phenotype, and cytokine production. In vitro experiments assessed effects of bilirubin and cytokines on MAIT cells. A murine SRLI model was established via intraperitoneal lipopolysaccharide (LPS) injection. Liver injury severity, inflammatory cytokines, and histopathology were compared between wild-type and MAIT cell-deficient mice. In the SRLI group, the proportion of peripheral blood MAIT cells was significantly decreased compared to the HC group. Regarding activation (CD69+, CD25+) and exhaustion (PD-1+, Tim-3+) phenotypes, the expression levels of CD69 and PD-1 were markedly upregulated relative to all other groups, while the expression of CD25 and Tim-3 was increased compared to the HC and NSLI groups. In vitro assays indicated that upon stimulation, these MAIT cells preferentially produced IL-17A, TNF-α, and granzyme B, suggesting a bias toward Th17-like differentiation. Elevated concentrations of bilirubin exacerbated both the activation and exhaustion of MAIT cells through a TCR-dependent mechanism. In the septic murine model, MAIT cells deficiency led to more severe liver injury, and higher serum levels of transaminases, bilirubin, and pro-inflammatory cytokines compared to wild-type. In the context of SRLI, peripheral blood MAIT cells exhibit a diminished frequency, functional impairment, and a phenotypic shift toward a Th17-like profile. Among these, bilirubin plays a key role. Ultimately, MAIT cells exert a protective role in sepsis-induced liver injury by suppressing excessive inflammatory responses.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.